ALK-positives NSCLC: Tyrosinkinaseinhibitor kurz vor der Zulassung
Crossref DOI link: https://doi.org/10.1007/s15015-015-1678-4
Published Online: 2015-03-19
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
red,
Text and Data Mining valid from 2015-03-01
